Trial intelligence / Profile preview

Prospective single-arm study of letrozole in uterine sarcoma

ChiCTR2000033695Phase 4Not yet recruiting

Sponsor
Shanghai Jiao Tong University
Start
Jun 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of letrozole in uterine sarcoma, sponsored by Shanghai Jiao Tong University. Primary endpoints: overall survival, pathological remission rate and 1 more. Planned start Jun 2020; status: not yet recruiting.

02

Drugs

letrozole
03

Conditions

uterine sarcoma

Beyond the preview

Go deeper on ChiCTR2000033695.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000033695.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call